Research - Novara, Piedmont, Italy
A startup founded in December 2016 and committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases. ChemICare's mission is the improvement of the quality of life of patients affected by Tubular Aggregate Myopathy, York Platelet Syndrome, Stormorken Syndrome and Acute Pancreatitis by the development of a therapy that restores the abnormal intracellular calcium level, a common feature of these three rare diseases.
Apache
WordPress.org
Google Font API
Google Tag Manager
Mobile Friendly
YouTube